Floatz logo

Therapeutic Asset Ratings

156 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
BMS-986482
Cancer
Bristol-Myers SquibbP1/2CC (40)
BMS-986490
Cancer
Bristol-Myers SquibbP1/2CC (40)
Ezobresib
Plasma Cell Myeloma
Bristol-Myers SquibbP1/2CC (40)
Pumitamig
Breast Cancer
Bristol-Myers SquibbP1/2CC (40)
Tazemetostat
Plasma Cell Myeloma
Bristol-Myers SquibbP1/2CC (40)
BMS-986360
Cancer
Bristol-Myers SquibbP1C (39)
BMS-986416
Cancer
Bristol-Myers SquibbP1C (39)
BMS-986463
Non-Small Cell Lung Carcinoma
Bristol-Myers SquibbP1C (39)
BMS-986500
Breast Cancer
Bristol-Myers SquibbP1C (39)
Mrtx1719
Mesothelioma
Bristol-Myers SquibbP1C (39)
Mrtx1719
Pancreatic Adenocarcinoma
Bristol-Myers SquibbP1C (39)
Orm-6151
Myelodysplastic Syndrome
Bristol-Myers SquibbP1C (39)
Anzurstobart
Myelodysplastic Syndrome
Bristol-Myers SquibbP1C (37)
BMS-986403
Lymphoma
Bristol-Myers SquibbP1C (37)
BMS-986460
Metastatic Prostate Carcinoma
Bristol-Myers SquibbP1C (37)
BMS-986506
Renal Cell Carcinoma
Bristol-Myers SquibbP1C (37)
Mrtx1719
Non-Small Cell Lung Carcinoma
Bristol-Myers SquibbP1C (37)
BMS-986484
Cancer
Bristol-Myers SquibbP1C (36)
BMS-986500
Cancer
Bristol-Myers SquibbP1C (36)
BMS-986504
Cancer
Bristol-Myers SquibbP1C (36)
Orm-6151
Acute Myeloid Leukemia
Bristol-Myers SquibbP1C (36)
BMS-986218
Castration-Resistant Prostate Carcinoma
Bristol-Myers SquibbP2C (33)
Deucravacitinib
Psoriasis
Bristol-Myers SquibbD (30)
Idecabtagene Vicleucel
B-Cell Chronic Lymphocytic Leukemia
Bristol-Myers SquibbD (30)
Idecabtagene Vicleucel
Non-Hodgkin Lymphoma
Bristol-Myers SquibbD (30)
Showing 126 to 150 of 156 assets
PreviousPage 6 of 7Next